Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Posted on by Pencis

Prof. Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Prof. Zhihui Zhang, Army Medical University, China

Prof. Zhihui Zhang is a distinguished researcher at Army Medical University, China, specializing in cardiovascular diseases and stem cell therapy. His work focuses on endothelial seed cells, myocardial infarction, and immunosuppressive capabilities of mesenchymal stem cell-derived extracellular vesicles. He has published extensively in leading journals such as Genes and Diseases, Science Bulletin, and Stem Cell Research and Therapy. Prof. Zhang’s research contributes to advancing early diagnosis and targeted interventions for coronary microvascular dysfunction. His expertise in molecular biology and regenerative medicine has made significant impacts in cardiovascular research and clinical applications.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Zhihui Zhang embarked on his academic journey with a deep passion for cardiovascular medicine. His early education laid a strong foundation in medical sciences, leading him to specialize in cardiology. His dedication and excellence in research and clinical practice positioned him for advanced studies and significant contributions to the field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Zhang is the Director of the Department of Cardiology at the First Affiliated Hospital (Southwest Hospital) of the Army Medical University in Chongqing. His leadership extends beyond the hospital as he holds multiple prestigious roles:

  • Member of the Great Vessel Group under the Cardiology Branch of the Chinese Medical Association
  • Member of the Cardiologists’ Association of the Chinese Medical Doctor Association
  • Deputy Director of the Committee for Structural Heart Disease under the China Human Health Promotion Association
  • Deputy Director of the Cardiology Branch of the Chongqing Medical Association, leading the Interventional Cardiology and Imaging Group

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCH:

Dr. Zhang is renowned for his expertise in interventional treatment of coronary heart disease and structural heart disease. His research focuses on:

  • Precise diagnosis and treatment of coronary heart disease
  • Interventional therapy for valvular heart diseases
  • Establishing a cohort for precise classification of myocardial ischemia
  • Creating a biobank and an artificial intelligence center for coronary angiography physiological assessment

Additionally, he has developed the professional Circa Met DB database, specializing in metabolic circadian rhythms.

🌍IMPACT AND INFLUENCE:

Dr. Zhang’s contributions have earned him numerous accolades, including:
🏆 Two first prizes for scientific progress in Chongqing
🏆 One first prize for scientific progress in Hubei Province
🏆 One second prize for military medical achievements

He has successfully led over 20 research projects, ranging from national natural science funds to key military and Chongqing talent programs. His pioneering work in cardiology has influenced national and military healthcare policies.

📖ACADEMIC CITATIONS:

Dr. Zhang has an outstanding publication record, with more than 30 SCI papers as the first or corresponding author (including co-first/co-corresponding). His research has been featured in top-tier journals such as:
📌 The Lancet
📌 Nature Metabolism
📌 Nature Communications
📌 Trends in Cell Biology

Additionally, he has contributed to drafting and setting 12 expert consensus documents, served as a deputy editor for two monographs, and contributed to nine other books. His work extends to two national invention patents, further solidifying his impact in the field.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

As a recipient of the Outstanding Youth Talent Fund in National Defense Bioscience, Dr. Zhang is recognized as a key innovator in cardiology. He has been honored as an Innovation Leading Talent by the Chongqing Talents Program and as a Science and Technology Talent by the Army.

His legacy will continue to shape the future of cardiovascular medicine through:
✅ Advanced research in interventional cardiology
✅ Expansion of AI-driven medical diagnostics
✅ Development of groundbreaking therapeutic techniques
✅ Mentorship and training of future cardiologists

🌟CONCLUSION:

Prof. Zhihui Zhang is a visionary leader in cardiology, blending clinical excellence, groundbreaking research, and technological innovation. His contributions have not only transformed patient care but also advanced global medical knowledge. His work will undoubtedly influence generations of medical professionals and redefine the future of cardiovascular treatment.

TOP NOTABLE PUBLICATIONS

Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction

Authors: Dingyuan Tian, Jie Li, Qingyuan Yang, Zhihui Zhang, Fang Deng

Journal: Genes and Diseases

Year: 2025

Circadian nutrition: is meal timing an elixir for fatigue?

Authors: Zhihui Zhang, Lu Yan, Jonas T. Treebak, Min-Dian Li

Journal: Science Bulletin

Year: 2025

Foxo1 drives the TGFβ1-dependent dichotomy of Th17 cell fates

Authors: Mengjuan Zhang, Yude Guan, Meijuan Han, Xiaomin Zhang, Song Zhang

Journal: Journal of Leukocyte Biology

Year: 2025

The short-term outcomes and risk factors of post-myocardial infarction ventricular septal rupture: a multi-center retrospective study

Authors: Wenjian Luo, Li Wen, Jinning Zhang, Zhexue Qin, Shiyong Yu

Journal: Journal of Cardiothoracic Surgery

Year: 2024

Sources and applications of endothelial seed cells: a review

Authors: Dan Deng, Yu Zhang, Bo Tang, Zhihui Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis

Authors: Yanan Duan, Xiteng Chen, Hui Shao, Jiawei Wang, Xiaomin Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Authors: Junjie Tang, Yaoming Liu, Yinghao Wang, Ping Zhang, Rong Lu

Journal: Biomarker Research

Year: 2024

Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001–2018

Authors: Diyu Cui, Chao Zhang, Yi Chen, Yu Zhang, Ping Zhu

Journal: Lipids in Health and Disease

Year: 2024

Single-cell transcriptomics enable the characterization of local extension in retinoblastoma

Authors: Yaoming Liu, Wei Hu, Yanjie Xie, Shengli Li, Rong Lu

Journal: Communications Biology

Year: 2024

Clinical characteristics of patients with moderate or severe valvular heart disease

Authors: Hao Gao, Yuzhu Lei, Haiyun Huang, Yanxiu Chen, Zhihui Zhang

Journal: Chinese Journal of Cardiology

Year: 2024

Dandan Tian | Hypertension | Best Researcher Award

Posted on by Pencis

Dr. Dandan Tian | Hypertension | Best Researcher Award

Dr.  Dandan Tian, Henan Provincial People’s Hospital, China

Dr. Dandan Tian is a medical professional at Henan Provincial People’s Hospital in China. With a focus on clinical practice, her expertise spans a variety of medical specialties, particularly in patient care and hospital management. Dr. Tian has made significant contributions to advancing healthcare in the region through her dedication to improving medical services and patient outcomes. She is well-regarded for her professional approach, collaboration with medical teams, and commitment to providing high-quality healthcare. Dr. Tian’s work has also involved research and development aimed at enhancing medical practices and addressing regional healthcare challenges.

Author Profile

Scopus Profile

EARLY ACADEMIC PURSUITS:

Dr. Dandan Tian’s academic journey laid a solid foundation for her distinguished career in hypertension prevention and treatment. After completing her formal medical education, she focused her studies on cardiovascular diseases, particularly hypertension, which has remained a central theme throughout her career. Her commitment to medical research, along with her clinical training, enabled her to understand the complexities of hypertension, and she quickly became passionate about improving treatment protocols and preventative care measures. Early on, her academic curiosity and dedication positioned her to contribute significantly to the growing body of knowledge in her field.

PROFESSIONAL ENDEAVORS:

Dr. Tian currently serves as the Attending Physician in the Hypertension Department of Henan Provincial People’s Hospital. This prestigious role allows her to apply her expertise in diagnosing and treating hypertension while maintaining a hands-on approach with patient care. Beyond her clinical responsibilities, Dr. Tian has taken on significant leadership roles, including Secretary of the Hypertension Prevention and Treatment Center of Henan Province and Secretary of the Hypertension Targeted Center Alliance. Her professional endeavors emphasize collaboration and innovation, as she continues to be a key player in hypertension care across the region.

CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Tian’s research focus has been on advancing hypertension prevention, treatment, and management through evidence-based practices. She has made substantial contributions to the field by leading one provincial-level research project and participating in multiple national-level research efforts. These research projects aim to enhance the clinical understanding of hypertension, explore new treatment methods, and implement effective prevention strategies. Her involvement in ministerial and provincial-level research further highlights her commitment to improving public health and addressing hypertension on a broader scale.

IMPACT AND INFLUENCE:

Dr. Tian’s impact extends beyond her clinical and research work. Her leadership in the Hypertension Prevention and Treatment Center of Henan Province and her membership in key medical societies, including the Henan Microcirculation Society, have solidified her influence in the medical community. Additionally, she plays a vital role in shaping healthcare policy and practice, particularly regarding hypertension management and prevention. Dr. Tian was recognized as an exemplary individual in disease prevention and control work by the province in 2021, reflecting the widespread acknowledgment of her contributions to public health.

ACADEMIC CITES AND RECOGNITION:

Dr. Tian’s research has garnered significant academic recognition, with citations from peers and professionals in the field of hypertension and cardiovascular health. Her work on hypertension prevention and treatment protocols has been widely cited, contributing to the academic discourse on hypertension management both within China and internationally. This recognition serves as a testament to the relevance and impact of her research in improving hypertension care practices.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Tian’s legacy is shaped by her pioneering work in hypertension prevention and her dedication to improving patient outcomes. Her research and clinical expertise continue to inspire future generations of healthcare professionals and researchers. Moving forward, Dr. Tian’s contributions are expected to pave the way for further advancements in hypertension management, particularly with her ongoing leadership in various professional committees and research projects. She is committed to continuing her work in hypertension treatment and prevention, and her future contributions are likely to have an enduring impact on the field.

CONCLUSION:

Dr. Dandan Tian’s career reflects a deep commitment to both the clinical and academic sides of hypertension management. Her early academic pursuits, professional endeavors, and continued contributions to research have established her as a leader in the field. Through her work, she has influenced both healthcare policy and patient care practices. With a lasting impact on hypertension prevention, Dr. Tian is poised to continue making significant contributions to the field, solidifying her place as a leading figure in cardiovascular health.

TOP NOTABLE PUBLICATIONS

Article: Effects of obesity on aging brain and cognitive decline: A cohort study from the UK Biobank

Authors: Li, P., Zhu, X., Huang, C., Su, J., Tian, D.

Journal: IBRO Neuroscience Reports

Year: 2025

Article: Joint Exposure to Ambient Air Pollutants, Genetic Risk, and Ischemic Stroke: A Prospective Analysis in UK Biobank

Authors: Li, P., Wang, Y., Tian, D., Su, J., Wang, M.

Journal: Stroke

Year: 2024

Article: Analysis of clinical and biochemical characteristics and left ventricular hypertrophy in patients with indeterminate saline infusion test results

Authors: Qu, H., Zhao, J., Wang, L., Hao, Y., Liu, M.

Journal: Frontiers in Endocrinology

Year: 2024

Article: Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study

Authors: Tian, D., Xu, Y., Wang, Y., Li, P., Li, X.

Journal: Frontiers in Cardiovascular Medicine

Year: 2024

Article: Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension

Authors: Xu, F., Shen, L., Yang, Y., Cao, X., Huang, G.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2023

Article: Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers

Authors: Xu, F., Tian, D., Shi, X., Sun, K., Chen, Y.

Journal: Pathology and Oncology Research

Year: 2021

Article: Highly sensitive and selective photoelectrochemical sensor for mercury(II) detection based on efficient Bi2MoO6 photoanode decorated with CuS

Authors: Zhang, X., Li, M., He, L., Zhang, J., Liu, M.

Journal: Journal of Alloys and Compounds

Year: 2021

Article: ANGPTL8/betatrophin improves glucose tolerance in older mice and metabolomic analysis reveals its role in insulin resistance in HepG2 cells

Authors: Xu, F., Wang, N., Li, G., Tian, D., Shi, X.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2021

Article: Modeling analysis of the relationship between atherosclerosis and related inflammatory factors

Authors: Li, H., Zhang, P., Yuan, S., Tian, D., Liu, M.

Journal: Saudi Journal of Biological Sciences

Year: 2017

Jihong Hu | Hypertension | Best Researcher Award 

Posted on by Pencis

🎓Current Position and Research Focus:

Dr. Hu holds a position at a respected institution where they continue to contribute significantly to the fields of preventive medicine and public health. Their ongoing research focuses on areas such as hypertension, cardiovascular risk assessment, and traditional Chinese medicine applications for chronic disease prevention. Through innovative studies and applied clinical work, Dr. Hu aims to enhance understanding of disease mechanisms and contribute to the development of preventive strategies in both Western and traditional Chinese medicine.

📚Academic Background:

Dr. Hu began their academic journey at Ningxia Medical University, earning a master’s degree in preventive medicine in 2000. Subsequently, they completed an undergraduate degree in the same field, graduating in 2003. Driven by a passion for epidemiology and health statistics, Dr. Hu went on to earn a doctorate from Peking Union Medical College in 2007. These degrees laid a solid foundation for a career devoted to advancing preventive medicine in both academic and clinical settings.

📝Publications and Scientific Achievements:

Over the last five years, Dr. Hu has contributed numerous papers to prestigious journals, often as the first author or corresponding author. Notable publications include research on:

  • Salt sensitivity and hypertension, investigating how salt substitutes impact blood pressure across different age groups.
  • PD-L1 expression in colorectal cancer, where Dr. Hu’s analysis provided insights into prognostic factors.
  • Gut microbiome research, exploring its association with diseases like obesity and hypertension.

These publications highlight Dr. Hu's versatility in addressing a wide range of health issues, often using meta-analyses to consolidate knowledge across studies.

🔬Ongoing Research Projects:

Dr. Hu actively participates in numerous research projects, often funded by prestigious bodies like the National Natural Science Foundation of China. Current projects include:

  • Internet+Chinese Medicine Integration: Investigating the role of Chinese medicine in preventing and controlling chronic diseases through technology.
  • Pediatric Intestinal Microecology: Examining how gut health affects respiratory infections in children.
  • Lumbar Disc Herniation Therapy: Standardizing Chinese medicine treatments for lumbar issues, focusing on Gansu’s regional medical practices.
  • Stroke and Traditional Medicine: Studying ischemic stroke through a traditional Chinese medicine perspective and assessing its diagnostic value.

These projects underscore Dr. Hu’s dedication to combining traditional Chinese medicine with modern epidemiology, aiming to offer holistic health solutions.

🔍Research Interests:

Dr. Hu’s research interests cover an impressive range within public health and epidemiology. Key areas include:

  • Chronic disease management with a particular focus on hypertension and cardiovascular risk.
  • The role of environmental and epigenetic factors in disease, particularly cardiovascular disease.
  • Traditional Chinese medicine and its integration with modern public health strategies to combat chronic illnesses.

Dr. Hu's diverse research portfolio reflects a commitment to improving population health through innovative, cross-disciplinary approaches.

🏆Awards and Scholarships:

Throughout their career, Dr. Hu has received several awards and scholarships recognizing their contributions to public health and epidemiology. While specific awards were not mentioned, it's clear from their impressive body of work that they are a valued researcher in China’s medical community.

🎤Professional Associations and Presentations:

Dr. Hu is an active member of various professional associations within the fields of preventive medicine and public health. Dr. Hu has also delivered several oral presentations at conferences and academic forums, sharing insights from studies on hypertension, cardiovascular health, and public health interventions.

🎓Training & Workshops: 

To stay updated in their field, Dr. Hu participates in training programs and workshops, often centered around epidemiological methods and data analysis. These workshops have likely included training on statistical software, meta-analysis techniques, and advanced bioinformatics relevant to health research.

🧪Laboratory Experience and Success Factors: 

Dr. Hu has extensive experience in laboratory-based research, having worked on projects involving stem cell transplantation, cytokine analysis, and cardiovascular biomarkers. Success in this domain can be attributed to strong analytical skills, dedication, and the ability to apply multi-disciplinary methods to complex health issues.

🛠️Tasks Completed as a Researcher:

Dr. Hu’s responsibilities have included:

  • Conducting data collection and statistical analysis on health data.
  • Leading clinical trials on new treatments and interventions.
  • Collaborating with traditional Chinese medicine experts to develop integrated health strategies.
  • Supervising junior researchers and contributing to project planning.

These tasks demonstrate Dr. Hu’s role as a key contributor to both team-based research and individual projects.

Citations:

Citations  201

h-index  5

i10-index  4

🌍Conclusion: 

Dr. Jihong Hu’s career reflects a deep commitment to advancing preventive medicine and public health in China. Through ongoing projects, publications, and a dedication to both epidemiology and traditional medicine, Dr. Hu bridges ancient practices with modern science. Their work not only contributes to medical knowledge but also to improved health outcomes across populations. With a track record of impactful research and a forward-thinking approach, Dr. Hu continues to lead in the integrated field of preventive medicine and epidemiology.

Top Notable Publications:

Hu, J.-H., Wang, S.-X., Wang, Y., ... Wang, L., Zhang, J. (2024). Association between salt sensitivity of blood pressure and dietary habits in survey population: A case-control study. Clinical Nutrition ESPEN, 64, 229–235.

Jin, L., Fang, S., Nan, Y., Hu, J., Jin, H. (2024). The effect of air pollutants on COPD-hospitalized patients in Lanzhou, China (2015–2019). Frontiers in Public Health, 12, 1399662.

Wang, L., Hu, J. (2024). Unraveling the gut microbiota's role in salt-sensitive hypertension: current evidences and future directions. Frontiers in Cardiovascular Medicine, 11, 1410623.

Lei, R., Zhang, L., Liu, X., ... Ren, Z., Luo, B. (2024). Residential greenspace and blood lipids in an essential hypertension population: Mediation through PM2.5 and chemical constituents. Environmental Research, 240, 117418.

Xiao, Y., Liu, C., Lei, R., ... Hu, J., Luo, B. (2023). Associations of PM2.5 composition and green space with metabolic syndrome in a Chinese essential hypertensive population. Chemosphere, 343, 140243.

Wang, S., Hu, J., Dong, G., ... Chen, X., Ding, F. (2023). Effects of bone marrow cells transplantation for acute myocardial infarction on cardiac function, infarct size, and clinical events: A meta-analysis. Chinese Medical Journal, 136(20), 2518–2520.

Zhou, E., Lei, R., Tian, X., ... Luo, B., Hu, J. (2023). Association between salt sensitivity of blood pressure and the risk of hypertension in a Chinese Tibetan population. Journal of Clinical Hypertension, 25(5), 453–462.

Hu, J., Thompson, B., Wang, S., ... Cao, Z., Wang, J. (2022). Rate and risk factors of metabolic components and component combinations according to hypertension status in Tibetans in a cross-sectional study. Medicine (United States), 101(43), E31320.

Lei, R., Wang, Z., Wang, X., ... Zhang, K., Bin Luo (2022). Effects of long-term exposure to PM2.5 and chemical constituents on blood lipids in an essential hypertensive population: A multi-city study in China. Ecotoxicology and Environmental Safety, 242, 113867.

Li, M.-Y., Wang, S.-X., Liu, X.-B., ... Cao, J., Hu, J.-H. (2021). Comparative study on the mortality rate of children under 5 years old between China and Russia from 1990 to 2017. Zhongguo Ertong Baojian Zazhi, 29(9), 1021–1025.